Evidence map›Paper›PMID 37974646›Full record

ArticleShoulder & elbow2023

Outcomes of reverse shoulder arthroplasty in patients under 55 years old: Results from the New Zealand joint registry.

Ryan Gao, Michael van der Merwe, Brendan Coleman, Matthew J Boyle, Christopher Ma Frampton, Marc Hirner

Abstract read
In one paragraph

Article in Shoulder & elbow, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryan GaoDepartment of Orthopaedic Surgery, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand.
Michael van der MerweDepartment of Orthopaedic Surgery, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand.ORCID https://orcid.org/0000-0003-3553-3352
Brendan ColemanDepartment of Orthopaedic Surgery, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand.
Matthew J BoyleAuckland Bone and Joint Surgery, Auckland, New Zealand.
Christopher Ma FramptonDepartment of Medicine, The University of Otago, Christchurch, New Zealand.
Marc HirnerDepartment of Orthopaedic Surgery, Whangarei Hospital, Northland District Health Board, Whangarei, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The appropriate age at which to perform reverse shoulder arthroplasty is controversial. The aim of this study was to compare the outcomes of reverse shoulder arthroplasty between younger and older patients. Methods: Patients who underwent primary reverse shoulder arthroplasty between January 2000 and December 2019 were identified from New Zealand Joint Registry records. Patients were stratified into two cohorts according to age at the time of surgery: < 55 years and ≥ 55 years. These two groups were then compared with regard to baseline characteristics, indications for surgery, revision rates, and patient-reported outcomes using the Oxford Shoulder Score and American Shoulder and Elbow Score (ASES). Results: A total of 5518 primary reverse shoulder arthroplasty cases were identified, with 75 patients < 55 years at the time of surgery (range: 34-54 years). The mean duration of follow-up was 2.36 years (range: 0.11-13.37 years) in the younger cohort and 3.10 years (range: 0.01-16.22 years) in the older patient cohort. Indications for surgery differed significantly between the two groups, with younger patients having higher rates of inflammatory arthritis ( Conclusion: Our early results suggest that younger patients undergoing reverse shoulder arthroplasty demonstrate high implant retention rates, comparable to older patients. Longer-term patient-reported outcomes in younger patients are required to guide appropriate patient selection for reverse shoulder arthroplasty. Level of evidence: Level III, retrospective case-control study.

Indexed as

<55 years oldreverse shoulder arthroplastyyoung reverse shoulder arthroplasty

Identifiers

PMID37974646
PMCPMC10649512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.